Search This Blog

Tuesday, June 30, 2020

Sinovac Biotech reports Q1 results

Sinovac Biotech (NASDAQ:SVA): Q1 GAAP EPS of -$0.07.
Revenue of $15.39M (-57.9% Y/Y)
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)